SCHEMBL13740745

SCHEMBL13740745

C=CN1CCC(C(=O)c2ccc(Br)cc2C)C1=O

nearest known ligand 0.38

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
FLT1 P17948 1/20 0.34
FLT4 P35916 1/20 0.34
KDR P35968 1/20 0.34
TSHR P16473 1/20 0.34
DRD2 P14416 1/20 0.33
DRD4 P21917 1/20 0.33
DRD3 P35462 1/20 0.33
ALDH1A1 P00352 3/20 0.32
MEN1 O00255 2/20 0.32
KMT2A Q03164 2/20 0.32
MAPK1 P28482 1/20 0.32
LMNA P02545 1/20 0.32
MAPT P10636 1/20 0.32
KDM4E B2RXH2 1/20 0.32
L3MBTL1 Q9Y468 1/20 0.32
HPGD P15428 2/20 0.32
GAA P10253 1/20 0.32
NPSR1 Q6W5P4 1/20 0.32
GPR6 P46095 1/20 0.32
TERT O14746 1/20 0.32

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL14194427 0.83
SCHEMBL16099787 0.83 MGLL (0.44) TSHRALDH1A1MEN1KMT2ALMNA
SCHEMBL28896483 0.83 KMT2A (0.43) ALDH1A1MEN1KMT2AMAPTKDM4E
SCHEMBL30029160 0.83 KMT2A (0.43) ALDH1A1MEN1KMT2AMAPTKDM4E
SCHEMBL13740391 0.78 DRD2 (0.35) DRD2DRD4DRD3
SCHEMBL28896620 0.76 MGLL (0.41) TSHRMAPK1LMNAHPGDGAA
SCHEMBL13740479 0.73 HTR1F (0.34) MGLL
SCHEMBL13335950 0.72 MGLL (0.41) TSHRALDH1A1LMNAMAPTKDM4E
SCHEMBL20872459 0.72 MCL1 (0.44) ALDH1A1MEN1KMT2AMAPTGAA
SCHEMBL13335882 0.72 KDM4E (0.39) ALDH1A1MEN1KMT2ALMNAMAPT

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20090215742-A1 AMIDE RESORCINOL COMPOUNDS PFIZER, INC. 2009-08-27 US disclosed
US-20090215742-A1 AMIDE RESORCINOL COMPOUNDS PFIZER, INC. 2009-08-27 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20090215742-A1 AMIDE RESORCINOL COMPOUNDS HSP90AB1, HSP90AA1, HSP90AB2P FLT1 3446/4885FLT4 3940/4885KDR 1989/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.